The National Cancer Institute offers a grant to conduct early phase clinical trials for cancer treatment and diagnosis under the Division of Cancer Treatment and Diagnosis. Applicants must align with NCI’s research mission and consult the DCTD website for program goals. Projects should meet NIH’s clinical trial definition and provide detailed trial information. Closing date for submissions is on Nov 12, 2020, at 12:00 AM EST.
Opportunity ID: 299845
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-560 |
| Funding Opportunity Title: | National Cancer Institute’s Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jan 05, 2018 |
| Last Updated Date: | Nov 12, 2020 |
| Original Closing Date for Applications: | Jan 07, 2021 |
| Current Closing Date for Applications: | Nov 12, 2020 |
| Archive Date: | Dec 12, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | State governments City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Special district governments For profit organizations other than small businesses Independent school districts Public housing authorities/Indian housing authorities Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Public and State controlled institutions of higher education County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The purpose of this Funding Opportunity Announcement (FOA) is to solicit research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials of relevance to the research mission of the National Cancer Institutes (NCI) Division of Cancer Treatment and Diagnosis (DCTD) programs. Applicants are strongly encouraged to consult the DCTD website, https://dctd.cancer.gov/, to learn more about the various program goals, research priorities and strategies developed to fight cancer. Applications submitted to this FOA must include studies that meet the National Institutes of Health (NIH) definition of a clinical trial (see NOT-OD-15-015 for details) and provide specific clinical trial information as described in this FOA. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-560.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Expired and Re-issued as PAR-21-033 | Nov 12, 2020 | |
| Jan 05, 2018 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-560 |
| Funding Opportunity Title: | National Cancer Institute’s Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jan 05, 2018 |
| Last Updated Date: | Nov 12, 2020 |
| Original Closing Date for Applications: | Jan 07, 2021 |
| Current Closing Date for Applications: | Nov 12, 2020 |
| Archive Date: | Dec 12, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | State governments City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Special district governments For profit organizations other than small businesses Independent school districts Public housing authorities/Indian housing authorities Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Public and State controlled institutions of higher education County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The purpose of this Funding Opportunity Announcement (FOA) is to solicit research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials of relevance to the research mission of the National Cancer Institutes (NCI) Division of Cancer Treatment and Diagnosis (DCTD) programs. Applicants are strongly encouraged to consult the DCTD website, https://dctd.cancer.gov/, to learn more about the various program goals, research priorities and strategies developed to fight cancer. Applications submitted to this FOA must include studies that meet the National Institutes of Health (NIH) definition of a clinical trial (see NOT-OD-15-015 for details) and provide specific clinical trial information as described in this FOA. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-560.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-560 |
| Funding Opportunity Title: | National Cancer Institute’s Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 05, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 07, 2021 |
| Archive Date: | Feb 12, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | City or township governments State governments Public and State controlled institutions of higher education Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Private institutions of higher education Independent school districts For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to solicit research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials of relevance to the research mission of the National Cancer Institutes (NCI) Division of Cancer Treatment and Diagnosis (DCTD) programs. Applicants are strongly encouraged to consult the DCTD website, https://dctd.cancer.gov/, to learn more about the various program goals, research priorities and strategies developed to fight cancer. Applications submitted to this FOA must include studies that meet the National Institutes of Health (NIH) definition of a clinical trial (see NOT-OD-15-015 for details) and provide specific clinical trial information as described in this FOA. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-560.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00237440 | Feb 15, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259064 | Feb 15, 2018 | Dec 15, 2020 | View |
Package 1
Mandatory forms
299845 RR_SF424_2_0-2.0.pdf
299845 PHS398_CoverPageSupplement_4_0-4.0.pdf
299845 RR_OtherProjectInfo_1_4-1.4.pdf
299845 PerformanceSite_2_0-2.0.pdf
299845 RR_KeyPersonExpanded_2_0-2.0.pdf
299845 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
299845 RR_Budget_1_4-1.4.pdf
299845 RR_SubawardBudget30_1_4-1.4.pdf
299845 PHS398_ModularBudget_1_2-1.2.pdf
299845 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
299845 RR_SF424_2_0-2.0.pdf
299845 PHS398_CoverPageSupplement_5_0-5.0.pdf
299845 RR_OtherProjectInfo_1_4-1.4.pdf
299845 PerformanceSite_2_0-2.0.pdf
299845 RR_KeyPersonExpanded_2_0-2.0.pdf
299845 PHS398_ResearchPlan_4_0-4.0.pdf
299845 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
299845 RR_Budget_1_4-1.4.pdf
299845 RR_SubawardBudget30_1_4-1.4.pdf
299845 PHS398_ModularBudget_1_2-1.2.pdf
299845 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
